全文获取类型
收费全文 | 1163篇 |
免费 | 103篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 56篇 |
妇产科学 | 11篇 |
基础医学 | 106篇 |
口腔科学 | 30篇 |
临床医学 | 103篇 |
内科学 | 374篇 |
皮肤病学 | 19篇 |
神经病学 | 63篇 |
特种医学 | 10篇 |
外科学 | 104篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 38篇 |
眼科学 | 22篇 |
药学 | 88篇 |
中国医学 | 4篇 |
肿瘤学 | 211篇 |
出版年
2024年 | 1篇 |
2023年 | 13篇 |
2022年 | 29篇 |
2021年 | 56篇 |
2020年 | 34篇 |
2019年 | 36篇 |
2018年 | 46篇 |
2017年 | 31篇 |
2016年 | 44篇 |
2015年 | 39篇 |
2014年 | 54篇 |
2013年 | 53篇 |
2012年 | 101篇 |
2011年 | 85篇 |
2010年 | 52篇 |
2009年 | 50篇 |
2008年 | 79篇 |
2007年 | 73篇 |
2006年 | 64篇 |
2005年 | 61篇 |
2004年 | 52篇 |
2003年 | 55篇 |
2002年 | 35篇 |
2001年 | 26篇 |
2000年 | 14篇 |
1999年 | 22篇 |
1998年 | 5篇 |
1997年 | 4篇 |
1996年 | 7篇 |
1995年 | 3篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 9篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 6篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1979年 | 5篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有1269条查询结果,搜索用时 15 毫秒
11.
12.
Dingli D Kyle RA Rajkumar SV Nowakowski GS Larson DR Bida JP Gertz MA Therneau TM Melton LJ Dispenzieri A Katzmann JA 《Blood》2006,108(6):1979-1983
An abnormal serum immunoglobulin free light chain (FLC) ratio at diagnosis may identify risk of progression to myeloma in patients with solitary bone plasmacytoma (SBP). In the cohort of 116 patients, 43 have progressed to myeloma, with a median time to progression of 1.8 years. The FLC ratio was determined in all 116 patients on serum collected at time of diagnosis and was abnormal in 54 patients (47%). An abnormal FLC ratio was associated with a higher risk of progression to myeloma (P = .039). The risk of progression at 5 years was 44% in patients with an abnormal serum FLC ratio at diagnosis compared with 26% in those with a normal FLC ratio. One to 2 years following diagnosis, a persistent serum M protein level of 5 g/L (0.5 g/dL) or higher was an additional risk factor for progression. A risk stratification model was constructed using the 2 variables of FLC ratio and M protein level: patients with a normal FLC ratio at baseline and M protein level less than 5 g/L (0.5 g/dL) at 1 to 2 years following diagnosis (low risk, n = 31); with either risk factor abnormal (intermediate risk, n = 26); and with both an abnormal FLC ratio and M protein level of 5 g/L (0.5 g/dL) or higher (high risk, n = 18). The corresponding progression rates at 5 years were significantly different in the low, intermediate, and high groups: 13%, 26%, and 62%, respectively (P < .001). 相似文献
13.
G. Ramalingam K. Venkata Saravanan T. Kayal Vizhi M. Rajkumar Kathirvelu Baskar 《RSC advances》2018,8(16):8516
Many synthesized semiconductor QDs materials are formed using trioctylphosphine oxide (TOPO) but it requires high temperature, is very expensive and is also hydrophobic. Our study deals with selective syntheses of CdSe and core–shell CdSe/ZnS quantum dots (QDs) in aqueous solution by a simple heating and refluxing method. It is more hydrophilic, needs less temperature, is economically viable and is eco-friendly. Bio-ligands, such as thioacetamide, itaconic acid and glutathione, were used as stabilizers for the biosynthesis of QDs. A simplified aqueous route was used to improve the quality of the colloidal nanocrystals. As a result, highly monodisperse, photoluminescent and biocompatible nanoparticles were obtained. The synthesized QDs were characterized by XRD, FTIR, confocal microscopy, ultraviolet (UV) absorption and photoluminescence (PL). The size of synthesized QDs was observed as 5.74 nm and the core–shell shape was confirmed by using XRD and confocal microscopy respectively. The QD nanoparticles showed antibacterial activity against pathogenic bacteria. The QDs could be applied for biological labelling, fluorescence bio-sensing and bio-imaging etc.Mystristic capped CdSe QDs with schematic diagram and formation mechanism of bio-taggable CdSe@ZnS QDs. 相似文献
14.
M. Sankar Johanna Rajkumar Dorai Sridhar 《Indian journal of pharmaceutical sciences》2015,77(5):556-562
The present study is designed to evaluate the efficacy of heptoplus a polyherbal formulation as an oral supplementary agent for isoniazid and rifampicin induced hepatotoxicity in rats. 50 and 100 mg/kg of heptoplus supplement were fed orally to the rats along with isoniazid and rifampicin and compared to rats treated with 100 mg/kg Liv 52 standard drug. Rats treated with isoniazid and rifampicin suffered from severe oxidative stress by the virtue of free radicals induced lipid per oxidation. As a result abnormal index of serum biochemical markers for liver function and increased liver lysosomal enzymes activity was observed. However rats nourished with 100 mg/kg of heptoplus and Liv 52 protected the liver from oxidative damage by maintaining normal antioxidant profile status and restored normal serum liver biochemical markers. Increased liver lysosomal enzymes activity is prevented in the rats supplemented with heptoplus and Liv 52. Histopathological analysis also revealed severe vascular changes and lobular necrosis in the treatment of isoniazid and rifampicin. Heptoplus (100 mg/kg) and Liv 52 supplemented rats liver apparently revealed normal architecture of liver. This study confirms that heptoplus has liver protective activity against Isoniazid and Rifampicin induced liver injury in rats, in par with Liv 52. 相似文献
15.
Muscle infaction is a rare complication in patients with diabetes mellitus, probably because of the rich vascular supply of
this tissue. We describe a patient with type 1 diabetes who had infarction of the muscles in her right thigh. We report, for
the first time, that the patient, in addition to an advanced microvascular disease in the muscle, had increased plasma total
homocysteine levels and increased platelet aggregation. These pathologies might have a synergistic effect on the development
of this rare complication and should be treated aggrssively to prevent further episodes. 相似文献
16.
17.
Objective
The purpose of this study was to eliminate orthodontic treatment in mild to moderate cases of condylar hyperplasia in its early stages by condylectomy.Patients and methods
A total of five patients (two females and three males) aged between 17 and 40 years were treated with unilateral condylectomy of the involved side without orthodontic treatment. All patients underwent standardized clinical and radiological examination at initial consultation, before surgery, immediately after surgery, and follow-up. Objective and subjective evaluation of temporomandibular joint (TMJ) included maximal incisal opening, lateral excursions, correction of facial asymmetry, occlusal harmony, TMJ pain, and jaw function. Results were recorded at 5-year follow-up.Results
In all our cases, we achieved good mouth opening and near to normal occlusion. Good facial aesthetics was obtained after 3 months postoperative follow-up without secondary orthodontic treatment.Conclusion
Thus, we conclude that treatment of mild to moderate cases of unilateral condylar hyperplasia during the inactive phase can be treated with condylectomy without orthodontic treatment, and it significantly improves long-term surgical outcomes. 相似文献18.
This case report illustrates the case of a patient who developed recurrent strokes after a pace maker lead was inserted into his left ventricle. It was removed successfully by the cardiothoracic surgeons but he remained very dependent functionally. This case highlights the importance of always reviewing the electrocardiogram and chest radiograph after the insertion of a pacemaker as late diagnosis of this complication can leave the patient with significant morbidity. 相似文献
19.
20.
Keats JJ Chesi M Egan JB Garbitt VM Palmer SE Braggio E Van Wier S Blackburn PR Baker AS Dispenzieri A Kumar S Rajkumar SV Carpten JD Barrett M Fonseca R Stewart AK Bergsagel PL 《Blood》2012,120(5):1067-1076
Emerging evidence indicates that tumors can follow several evolutionary paths over a patient's disease course. With the use of serial genomic analysis of samples collected at different points during the disease course of 28 patients with multiple myeloma, we found that the genomes of standard-risk patients show few changes over time, whereas those of cytogenetically high-risk patients show significantly more changes over time. The results indicate the existence of 3 temporal tumor types, which can either be genetically stable, linearly evolving, or heterogeneous clonal mixtures with shifting predominant clones. A detailed analysis of one high-risk patient sampled at 7 time points over the entire disease course identified 2 competing subclones that alternate in a back and forth manner for dominance with therapy until one clone underwent a dramatic linear evolution. With the use of the Vk*MYC genetically engineered mouse model of myeloma we modeled this competition between subclones for predominance occurring spontaneously and with therapeutic selection. 相似文献